Pfizer, Moderna COVID vaccines face new safety probe in Europe over possible link to skin condition, 2 kidney disorders Biogen's controversial Alzheimer's med Aduhelm turned away by VA on efficacy and safety worries Aetna launching nationwide virtual primary care solution As biotech debates vaccine mandates, one CEO tries to convince the 3% that got away HIMSS21: Your healthcare organization is crippled by ransomware. Should you pay the attackers? Big Pharma’s Q2 growth, ranked: Regeneron, Pfizer lead the way as sales rebound from pandemic depths BD finds new global finance chief in 20-year Johnson & Johnson vet Texas governor asks hospitals to delay elective procedures amid COVID surge Overcoming resistance to cancer immunotherapy by targeting garbage-cleaning cells in tumors Lawsuit charges HCA operating hospital monopoly in North Carolina COVID-19 tracker: CDC recommends vaccines for pregnant women; California to require jabs for teachers, school staff Featured Story | By Kevin Dunleavy The European Medicines Agency is trying to determine if mRNA vaccines can trigger an allergic skin reaction called erythema multiforme or two kidney disorders. It has requested additional data from Pfizer, BioNTech and Moderna. read more |
| |
|---|
|
Top Stories By Fraiser Kansteiner The Department of Veterans Affairs decided not to include Biogen’s drug aducanumab on its formulary, which its pharmacy benefit manager (PBM) credited to a “lack of evidence of a robust and meaningful clinical benefit,” plus safety concerns. read more By Paige Minemyer The new solution is backed by Teladoc Health's physician-led care team model and harnesses Aetna's provider network and the slate of services provided by CVS Health, the insurer's parent company. read more By Kyle LaHucik The Delta variant has sent shockwaves across the world as people began to emerge from more than a year of isolation. The workplace has become a new line of defense against the pandemic. Fierce Biotech surveyed a range of biotechs to see how they are responding to the wave of vaccination mandates. read more By Dave Muoio There are few incentives for hamstrung health organizations to hold out against their cyberattackers. But whether they decide to pay, hospitals and payers can take steps to improve their chances during a ransomware crisis, experts said at HIMSS21. read more By Kevin Dunleavy Drug sales are up, with some therapy areas rebounding faster than others, quarterly earnings show. And while the recovery is underway, there’s still a long ride ahead to return to the industry’s pre-pandemic landscape. read more By Andrea Park In his new role, DelOrefice will oversee not only the company’s entire global finance organization, but also its technology and global services business division, replacing retiring CFO Christopher Reidy. read more By Robert King Texas Gov. Greg Abbott is asking hospitals to voluntarily halt elective procedures and for out-of-state staffing help as COVID-19 surges. read more By Angus Liu Combining immunotherapy, anti-angiogenic drugs and chemotherapy to treat non-small cell lung cancer hasn't proven to be all that effective. Now, a new study suggests that a four-drug combination including a CSF1R inhibitor can target tumor-associated macrophages and improve the anti-tumor response. read more By Robert King North Carolina residents are suing HCA Healthcare, charging the hospital system with operating a monopoly in the western part of the state. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner The CDC now recommends pregnant women get vaccinated against the virus, saying the benefits outweigh any known risks. California has become the first state to require its school teachers and staff to get vaccinated against COVID-19 or face weekly testing. Plus more headlines. read more |
